Moolec Science (MLEC) Total Debt (2022 - 2025)
Moolec Science's (MLEC) quarterly Total Debt came in at $228.5 million in Q2 2025, down 36.84% year-on-year from $361.8 million in Q2 2024, and up 1079.55% quarter-over-quarter from $19.4 million in Q4 2024.
Moolec Science (MLEC) Total Debt (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Total Debt across 4 years of filings, most recently posting $228.5 million for Q2 2025.
- Total Debt for Q2 2025 came in at $228.5 million, down 36.84% year-over-year; the trailing twelve-month figure through Jun 2025 was $228.5 million (down 36.84% YoY), and the FY2025 annual result was $228.5 million, down 36.84% from the prior year.
- Total Debt came in at $228.5 million for Q2 2025 at Moolec Science, up from $19.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $361.8 million in Q2 2024 to a low of $1.2 million in Q1 2023.
- The 4-year median for Total Debt is $14.0 million (2023), against an average of $67.2 million.
- Across the five-year window, Total Debt surged 2389.38% in 2024 and sank 36.84% in 2025, its largest moves.
- Moolec Science's Total Debt stood at $1.7 million in 2022, then soared by 707.9% to $13.5 million in 2023, then jumped by 43.88% to $19.4 million in 2024, then surged by 1079.55% to $228.5 million in 2025.
- The last three Total Debt figures came in at $228.5 million (Q2 2025), $19.4 million (Q4 2024), and $18.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 228.50 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 361.76 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 13.46 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 14.53 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.67 Mn |